![Sphere that has the top right fourth removed (exposed) Colors from left are orange, dark blue with orange dots, light blue with horizontal lines, then black. Inside the exposure is green and black with boxes.](/sites/default/files/styles/featured_square_large/public/2024-06/slicer.jpg?h=56311bf6&itok=bCZz09pJ)
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (28)
- (-) Frontier (24)
- (-) Isotopes (27)
- (-) Nuclear Energy (54)
- (-) Security (11)
- (-) Space Exploration (12)
- 3-D Printing/Advanced Manufacturing (37)
- Advanced Reactors (8)
- Artificial Intelligence (46)
- Big Data (22)
- Bioenergy (50)
- Biology (58)
- Biotechnology (11)
- Buildings (18)
- Chemical Sciences (22)
- Clean Water (14)
- Climate Change (48)
- Composites (6)
- Computer Science (82)
- Coronavirus (17)
- Critical Materials (2)
- Cybersecurity (14)
- Decarbonization (45)
- Education (1)
- Emergency (2)
- Energy Storage (28)
- Environment (101)
- Exascale Computing (25)
- Fossil Energy (4)
- Fusion (30)
- Grid (23)
- High-Performance Computing (43)
- Hydropower (5)
- ITER (2)
- Machine Learning (22)
- Materials (41)
- Materials Science (44)
- Mathematics (6)
- Mercury (7)
- Microelectronics (2)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (35)
- Net Zero (8)
- Neutron Science (47)
- Partnerships (16)
- Physics (28)
- Polymers (8)
- Quantum Computing (20)
- Quantum Science (30)
- Renewable Energy (1)
- Simulation (30)
- Software (1)
- Summit (30)
- Sustainable Energy (43)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Balendra Sutharshan](/sites/default/files/styles/list_page_thumbnail/public/2021-06/2021-P01348.jpg?h=d33ebf6f&itok=qwQNPmu1)
In the mid-1980s, Balendra Sutharshan moved to Canada from the island nation of Sri Lanka. That move set Sutharshan on a path that had him heading continent-spanning collaborations and holding leadership posts at multiple Department of Energy
![Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Deborah%20Frincke%20profile_0.jpg?h=8caed45b&itok=0eTC4gMH)
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
![Vittorio Badalassi, left, of Oak Ridge National Laboratory leads the Fusion Energy Reactor Models Integrator, or FERMI, project, and collaborates with ORNL computational physicist David Green. FERMI applies fission platforms to fusion reactor design. Credit: Commonwealth Fusion Systems and Colby Earles/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/FERMI_v3_web_art_for_landing_page_carousel_2021_04_20_1.jpg?h=d1cb525d&itok=y2KEq11p)
Oak Ridge National Laboratory expertise in fission and fusion has come together to form a new collaboration, the Fusion Energy Reactor Models Integrator, or FERMI
![Brenda Smith, shown here working with a gas viscometer in her research lab, is one of several people concurrently researching the thermophysical properties of feedstock gas. Their research will support computational researchers who are designing processes to separate isotopes. Credit: Carlos Jones/ORNL, US Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/2021-P01103_0.jpg?h=13f436e5&itok=lMLI1EqU)
For years Brenda Smith found fulfillment working with nuclear batteries, a topic she’s been researching as a chemist at Oak Ridge National Laboratory.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Nuclear engineer Nesrin Ozgan Cetiner led ORNL’s collaboration with AMS Corp. to test instrument and control sensors for the next generation of nuclear power reactor technology. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/Nesrin_Cetiner_AMS_article_2021-P02224%5B2%5D.jpg?h=acaf5000&itok=YDUKbigy)
Toward the goal of bringing the next generation of nuclear power reactor technology online this decade, ORNL and Analysis and Measurement Services Corporation have successfully completed loop testing of instrument and control sensors for an advanced reactor design for small modular reactors.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Technicians John Dyer and T. Dyer use a manipulator arm in a shielded cave in ORNL’s Radiochemical Engineering Development Center to separate concentrated Pm-147 from byproducts generated through the production of Pu-238.](/sites/default/files/styles/list_page_thumbnail/public/2021-03/Promethium%20feature_0.jpg?h=a1f525db&itok=6XSsJdot)
A new method developed at Oak Ridge National Laboratory proves one effort’s trash is another’s valuable isotope. One of the byproducts of the lab’s national plutonium-238 production program is promethium-147, a rare isotope used in nuclear batteries and to measure the thickness of materials.